New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 11, 2013
09:58 EDTMWV, BBRY, WNR, TYG, LH, AVNR, SNI, TSO, OI, ENZY, HFC, GRAOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Avanir (AVNR) downgraded to Neutral from Buy at Mizuho... BlackBerry (BBRY) downgraded to Sell from Neutral at Citigroup... Enzymotec (ENZY) downgraded to Underperform from Buy at BofA/Merrill... LabCorp (LH) downgraded to Hold from Buy at Canaccord... MeadWestvaco (MWV) downgraded to Underperform from Market Perform at BMO Capital... Owens-Illinois (OI) downgraded to Neutral from Buy at Goldman... Tortoise Energy (TYG) downgraded to Underperform from Neutral at BofA/Merrill... W.R. Grace (GRA) downgraded to Neutral from Outperform at RW Baird... Tesoro (TSO) downgraded to Accumulate from Buy at Tudor Pickering... Western Refining (WNR) downgraded to Hold from Accumulate at Tudor Pickering... HollyFrontier (HFC) downgraded to Hold from Accumulate at Tudor Pickering... Scripps Networks (SNI) downgraded to Sell from Neutral at Citigroup.
Check below for free stories on AVNR;BBRY;ENZY;LH;MWV;OI;TYG;GRA;TSO;WNR;HFC;SNI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 23, 2014
06:11 EDTGRAW.R. Grace reports Q1 Catalysts Technologies sales up 6.8% to $284.5M
Subscribe for More Information
06:03 EDTGRAW.R. Grace reports Q1 adjusted EPS 77c, consensus 74c
Reports Q1 revenue $744.5M, consensus $739.13M
05:49 EDTOIOwens-Illinois initiated with a Neutral at JPMorgan
Target $36.
April 22, 2014
07:37 EDTWNR, HFC, TSOIncreased refiner exporting playing a role in high gas prices, WSJ says
Gasoline futures climbed a bit over 1% a gallon Monday and are up 11% for the year. While gasoline prices often rise ahead of summer, more gasoline being exported by refiners plays a "prominent" role in the current rally, said The Wall Street Journal, citing analysts. Publicly traded refiners include HollyFrontier (HFC), Marathon Oil (MRO), Phillips 66 (PSX), Tesoro (TSO), Valero (VLO) and Western Refining (WNR). Reference Link
April 21, 2014
14:05 EDTENZYNeptune says '348 patent still valid, to appeal USPTO decision
Neptune Technologies & Bioressources (NEPT) announced that the United States Patent and Trademark Office, or USPTO, recently issued a Right of Appeal Notice in an inter partes reexamination of Neptune's '348 patent. Despite the USPTO's decision, the '348 patent is still valid as Neptune has the right to appeal, which it intends to do, the company said. "Enzymotec (ENZY), in yet another clear attempt to shift focus from the on-going International Trade Commission investigation of its infringement of other Neptune patents, issued a press release addressing the '348 Patent decision. However, Enzymotec failed to highlight that the decision has no impact on the ITC investigation into infringement of Neptune's other composition of matter patents, as well as related federal court actions initiated by Neptune against Enzymotec and its distributors. Furthermore, the decision has no impact on Neptune's license agreements with Rimfrost and Aker BioMarine," said Neptune.
10:01 EDTHFCOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:41 EDTHFCHollyFrontier downgraded to Sector Perform from Outperform at Howard Weil
Subscribe for More Information
08:09 EDTENZYEnzymotec says USPTO issues final decision, rejects all claims in Neptune patent
Subscribe for More Information
April 17, 2014
09:00 EDTTSOTesoro falls 11.6%
Subscribe for More Information
08:32 EDTLHARCA Biopharma announces screening of first patient in Phase 2B/3 trial
ARCA biopharma announced that the first patient has been genetically screened in GENETIC-AF, its Phase 2B/3 adaptive design clinical trial. The GENETIC-AF trial will evaluate Gencaro as a potential treatment for the prevention of atrial fibrillation in patients with heart failure and/or left ventricular dysfunction who also have a specific genotype of the beta-1 adrenergic receptor, which is believed to be present in approximately 50% of the U.S. population. There are currently seven active clinical trial sites recruiting patients for GENETIC-AF. The company anticipates having approximately 50 clinical trial sites for the Phase 2B portion of the trial. Last week, ARCA hosted the initial GENETIC-AF Investigator Meeting which brought together the physicians and research coordinators participating in the trial for information sharing and study-specific training.
05:39 EDTWNRWestern Refining announces new Delaware Basin pipeline project
Western Refining (WNR) announced an additional pipeline project in the Delaware Basin. Subject to approvals, Western plans to construct a new pipeline originating near Western Refining Logistics, LP's (WNRL) existing Mason Station crude oil gathering facility in Reeves County, Texas terminating at a new crude oil gathering facility at Wink Station in Winkler County, Texas. The pipeline, approximately 40 miles in length, will be capable of receiving and transporting up to 125,000 barrels per day of light crude oil and condensate for delivery to common carrier pipelines at Wink, Texas and is expected to be in service by mid-2015.
April 16, 2014
13:41 EDTBBRYBlackBerry's troubles spawn entrepreneurs in Canada, NY Times reports
Subscribe for More Information
09:04 EDTBBRYBlackBerry announces investment by several leading Canadian organizations
BlackBerry announced that several leading Canadian customers are deploying BlackBerry Enterprise Service 10, or BES10, including: Volker Stevin, City of Waterloo and Samuel, Son & Co., Limited. According to J. Gold Associates, over the next year or two the average enterprise user will employ three to five personal devices and use eight to 10 business applications. With the growing need for enterprise users to connect to at least five different enterprise systems, such as VPN, email and the cloud, to perform work-related tasks, the management and security of devices will become increasingly more complex to control without the right enterprise mobility management, or EMM, solution. Migrating to BlackBerry's EMM solution allows organizations to seamlessly manage devices, operating systems, applications and security. The City of Waterloo continues its long-standing partnership with BlackBerry in innovating and injecting new ideas and technologies to provide valued services that help build the best quality of life for its citizens. In addition to deploying BES10 and BlackBerry 10 smartphones for its workforce, the City of Waterloo also worked with BlackBerry to develop the Ping Street mobile application on the BlackBerry OS platform. Samuel, Son & Co., Limited, Canada's oldest and largest metals service center and metal manufacturing company, has chosen BES10 and BlackBerry 10 smartphones as their core end-to-end business mobility solution.
April 15, 2014
15:53 EDTBBRYFord's new My Touch with BlackBerry software slated for year end, WSJ says
Subscribe for More Information
08:03 EDTBBRYBlackBerry invests in NantHealth for integrated end-to-end healthcare solutions
Subscribe for More Information
April 13, 2014
17:05 EDTBBRYBlackBerry plans to release 'Heartbleed' patches, Reuters says
BlackBerry is planning a release of security updates for messaging software for Android and iOS devices by Friday to deal with vulnerabilities in programs related to the "Heartbleed" security threat, says Reuters. Reference Link
April 10, 2014
12:13 EDTBBRYBlackBerry CEO: No intention of selling handset unit, Globe and Mail reports
BlackBerry CEO John Chen said his comments that he would consider exiting the handset business were taken out of context, and that there are no immediate plans to sell the business, The Globe and Mail reports. Reference Link
April 9, 2014
19:49 EDTBBRYBlackBerry would consider handset unit sale, Reuters says
Subscribe for More Information
10:06 EDTOIOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:16 EDTOIOwens-Illinois initiated with a Neutral at Credit Suisse
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use